Insmed Incorporated

366 articles with Insmed Incorporated

• Insmed Incorporated Announces Proposed Public Offering Of Common Stock

  3/6/2006

• Insmed Incorporated To Announce 2005 Fourth Quarter And Year End Financial Results

  2/23/2006

• University of Rochester Initiates Phase 2 Clinical Trial Of Insmed Incorporated's iPlex For The Treatment Of Myotonic Muscular Dystrophy; Trial Funded By National Institutes of Health (NIH) And MDA Grants

  1/4/2006

• FDA Approves Insmed Incorporated's Orphan Drug, IPLEX, For The Treatment Of Severe Primary IGF-1 Deficiency; The First Once-Daily Therapy For The Treatment Of Severe Primary IFG-1 Deficiency

  12/13/2005

• Tercica, Inc. Files Unfair Business Practices Lawsuit Against Insmed Incorporated

  12/7/2005

• Insmed Incorporated To Present At The C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference

  10/24/2005